back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-28 14:35 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+3,671 vol |
41,994 | |
| Filed 2024-03-20 12:58 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$17,569
+2,067 vol $8.50 each |
38,323 | |
| Filed 2024-03-20 12:56 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,134 vol |
36,256 | |
| Filed 2024-03-20 12:52 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,960
+253 vol $7.75 each |
32,122 | |
| Filed 2024-03-20 12:48 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,284
+1,069 vol $7.75 each |
31,869 | |
| Filed 2023-04-03 10:11 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+4,133 vol |
30,800 | |
| Filed 2023-04-03 10:10 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,529 vol |
26,667 | |
| Filed 2023-04-03 10:10 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-7,058 vol |
23,138 | |
| Filed 2023-04-03 10:04 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+4,133 vol |
30,196 | |
| Filed 2023-04-03 10:03 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,529 vol |
26,063 | |
| Filed 2023-04-03 10:01 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+7,058 vol |
22,534 | |
| Filed 2023-03-14 11:28 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$570.40
+80 vol $7.13 each |
15,476 | |
| Filed 2023-03-14 11:25 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,169
+884 vol $8.11 each |
15,396 | |
| Filed 2022-04-01 11:50 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$29,842
+3,283 vol $9.09 each |
14,512 | |
| Filed 2022-03-31 12:59 Tx date 2022-03-29 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-9,110.88
-999 vol $9.12 each |
7,760 | |
| Filed 2022-03-31 12:56 Tx date 2022-03-29 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-8,118.01
-901 vol $9.01 each |
8,759 | |
| Filed 2022-03-31 12:55 Tx date 2022-03-29 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-8,920
-1,000 vol $8.92 each |
9,660 | |
| Filed 2022-03-31 12:54 Tx date 2022-03-29 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-15,651.59
-1,741 vol $8.99 each |
10,660 | |
| Filed 2022-03-28 19:25 Tx date 2022-03-24 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-39,622.59
-5,193 vol $7.63 each |
11,229 | |
| Filed 2022-03-23 12:27 Tx date 2022-03-21 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,341.60
-607 vol $8.80 each |
16,422 | |
| Filed 2022-03-23 10:29 Tx date 2022-03-18 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-68,697.51
-8,247 vol $8.33 each |
17,029 | |
| Filed 2022-03-14 23:12 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,181
+672 vol $7.71 each |
25,276 | |
| Filed 2021-03-23 17:20 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$29,236
+4,005 vol $7.30 each |
24,604 | |
| Filed 2021-03-10 22:52 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,383
+473 vol $5.04 each |
20,599 | |
| Filed 2021-03-10 22:46 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,383
+473 vol $5.04 each |
||
| Filed 2020-04-05 22:05 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+6,981 vol |
20,126 | |
| Filed 2020-03-13 14:17 Tx date 2019-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,188
+1,278 vol $7.19 each |
13,145 | |
| Filed 2019-03-22 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$22,892
+2,785 vol $8.22 each |
12,401 | |
| Filed 2019-03-04 Tx date 2018-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$16,945
+1,780 vol $9.52 each |
11,867 | |
| Filed 2018-03-28 Tx date 2017-12-31 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$16,495
+1,841 vol $8.96 each |
10,087 | |
| Filed 2018-01-12 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$21,100
+2,198 vol $9.60 each |
9,616 | |
| Filed 2017-07-05 Tx date 2015-01-12 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-05 Tx date 2017-07-04 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$65,994
+8,246 vol $8.00 each |
8,246 | |
| Filed 2017-03-20 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$20,146
+2,741 vol $7.35 each |
7,418 | |
| Filed 2016-02-17 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Raghubir, Sharan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$11,780
+1,900 vol $6.20 each |
4,677 |